Moderna and Merck shares soared on Wednesday after the companies said a personalized mRNA treatment hit its target of preventing skin cancer from recurring or spreading in a late-stage clinical trial.

Can AI help us fight cancer more effectively? Moderna is putting that promise to the test, using AI to help design personalized treatments and rethink how a pharmaceutical company operates. Its ...